Cerebral glucose hypometabolism, characterized by impaired glucose uptake and utilization related to brain insulin resistance [2, 3], and progressive mitochondrial dysfunction with aging [4] have both been recently associated with AD and suggest involvement of energy metabolism alterations in AD pathophysiology. This evidence concerns the gene INS and Alzheimer disease.